Literature DB >> 709826

High-performance liquid-chromatographic assay of aminoglycoside antibiotics in serum.

J P Anhalt, S D Brown.   

Abstract

We describe procedures for the high-performance liquid-chromatographic assay of gentamicin, amikacin, and tobramycin in serum. The aminoglycoside antibiotic is extracted from serum by using a CM-Sephadex column and is measured by reversed-phase, ion-pair chromatography. Continuous-flow, post-column derivatization with o-phthalaldehyde is used to form fluorescent products for detection. An internal standard is used in each assay. Synthesis of 1-N-acetylgentamicin C1, the internal standard for the gentamicin assay, is described. For each procedure, concentration and instrument response are linearly related in the range of therapeutically important concentrations. The methods are precise and results correlate well with results obtained by bioassay. The between-day CV (n = 10) for each procedure was less than 4%. No substances have been detected in clinical specimens that interfere with these chromatographic procedures. The possible use of these methods for analysis for other aminoglycoside antibiotics is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 709826

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  16 in total

1.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

2.  Lack of tobramycin distribution into saliva.

Authors:  J E Houglum; P J Cascella; G B Edwards
Journal:  Pharm Res       Date:  1984-05       Impact factor: 4.200

3.  Comparison of the latex agglutination inhibition assay for tobramycin with radioimmunoassay.

Authors:  S D Sears; H C Standiford; D Bernstein; H C Nipper; B A Tatem; U Smalls; E Caplan
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

Review 4.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

5.  Determination of kanamycin concentration in serum by substrate-labeled fluorescent immunoassay.

Authors:  A F DeCastro; J D Place; C T Lam; C Patel
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

6.  Comparison of a simplified liquid chromatographic assay of gentamicin in serum with enzyme immunoassay and bioassay.

Authors:  L Essers
Journal:  Eur J Clin Microbiol       Date:  1982-12       Impact factor: 3.267

7.  Collaborative evaluation of the microbial profile system for quantitative antimicrobial susceptibility testing.

Authors:  E H Gerlach; R N Jones; A L Barry
Journal:  J Clin Microbiol       Date:  1983-03       Impact factor: 5.948

8.  Comparison of radioimmunoassay with a new immunofluorescent method (FIAX) for measuring tobramycin in serum.

Authors:  D A Bruckner; J A Hindler; W J Martin; R Palmer
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

9.  Performance characteristics of bioassay, radioenzymatic assay, homogeneous enzyme immunoassay, and high-performance liquid chromatographic determination of serum gentamicin.

Authors:  C J Delaney; K E Opheim; A L Smith; J J Plorde
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

10.  Evaluation of an enzyme immunoassay for serum gentamicin.

Authors:  T D O'Leary; R M Ratcliff; T D Geary
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.